HCPCS code Q4115 – Cryopreserved human dermal allograft (Alloskin)

Key takeaways

HCPCS code Q4115 describes Alloskin, AlloSource’s cryopreserved, meshed human dermal allograft, billed per square centimeter of graft applied.

Q4115 is billed with a CPT application code from 15271-15278 on the same claim. The wound’s site and total surface area decide which one.

Medicare coverage requires documented wound chronicity of at least 30 days and failure of standard care before the skin substitute is applied.

Pabau’s practice software keeps wound measurements and graft details in the patient record, and its claims management submits Q4115 claims and tracks denials.

HCPCS code Q4115: official descriptor and product details

HCPCS code Q4115 is defined in the CMS HCPCS Level II file as Alloskin, per square centimeter (add-on, list separately in addition to primary procedure). According to the Centers for Medicare and Medicaid Services (CMS) HCPCS overview, Q-series codes are temporary codes. In the Q4101-Q4440 skin substitute range, each code is assigned to specific products, so Medicare can tell one graft from another on a claim.

The product billed under Q4115 is Alloskin, a meshed human dermal allograft from AlloSource, a nonprofit tissue bank. In addition, it is a meshed, split-thickness dermal graft, cryopreserved by controlled-rate freezing to maintain natural cell morphology. Importantly, it is human tissue, not a synthetic or xenograft product.

However, AlloSource sells two related grafts under their own codes: AlloSkin RT (Q4123) and AlloSkin AC (Q4141). Q-code assignments can change each year when CMS adds, reassigns or deletes codes. Verify the current product mapping in the active HCPCS Level II file before billing. Our HCPCS procedure codes library covers the other skin substitute codes in the range.

Clinical indications: when Q4115 Alloskin is medically appropriate

Alloskin is used on acute wounds such as burns and dehisced surgical wounds, and on chronic ulcers. Therefore, Medicare coverage rules focus on the chronic ones. For a chronic ulcer, most LCDs expect at least 30 days of documented standard wound care that failed before the first application. However, the exact threshold and wording vary by Medicare Administrative Contractor (MAC) jurisdiction.

The failed standard care you document typically includes debridement, moist wound therapy, offloading (for diabetic foot ulcers), and compression therapy (for venous leg ulcers). Without this documented treatment history, Medicare will deny Q4115 as not medically necessary.

• Diabetic foot ulcers (DFU) – full-thickness ulcers in patients with documented diabetes, failing standard offloading and wound care for at least 30 days
• Venous leg ulcers (VLU) – chronic venous ulcers below the knee, with documented compression therapy failure over the required duration
• Pressure injuries (stages 3-4) – full-thickness pressure injuries where conservative management has been insufficient
• Non-healing surgical or traumatic wounds – select cases where standard healing has failed and coverage criteria are met per the applicable LCD

Also, the wound must be measured and photographed at baseline and at each subsequent application visit. In particular, size in sq cm must appear in the clinical note and must match the units billed on the claim.

CPT application codes billed alongside HCPCS code Q4115

Q4115 is a product code. In other words, it describes the skin substitute itself, not the act of applying it. Therefore, providers bill a separate CPT application code on the same claim to capture the surgical work of placing the graft. CMS expects both codes together, and Q4115 submitted without an application CPT will hit a claim edit or denial.

The correct application CPT depends on two facts: the wound’s anatomical site and its total surface area. For example, the grid below shows how those two choices lead to one of four code pairs.

Foot ulcers use 15275/15276 when the total wound area is under 100 sq cm, or 15277/15278 when it is 100 sq cm or more. In contrast, venous ulcers on the lower leg, above the foot, use 15271/15272 under 100 sq cm, or 15273/15274 at 100 sq cm and above. Billers who pick the code before confirming the anatomical site make an avoidable error on Q4115 claims.

ICD-10 diagnosis codes that support HCPCS code Q4115

Medicare and most commercial payers require the diagnosis code to demonstrate medical necessity at the specificity level the applicable LCD demands. Furthermore, codes must capture laterality, depth (where required), and the underlying condition. As a result, unspecified codes are a leading denial cause on Q4115 claims.

When billing diabetic ulcers, use E11.621 as the primary code and sequence L97.x as an additional code to document the ulcer’s site and depth. Moreover, the LCD for your MAC may require the L97 code to be present, not just the diabetes code. Check the applicable LCD documentation requirements before submitting.

Medicare reimbursement for Q4115

From January 1, 2026, Medicare pays for Q4115 as an incident-to supply rather than as a biological. This change comes from the CY 2026 Physician Fee Schedule final rule (CMS-1832-F). Likewise, the CY 2026 OPPS final rule applies the same approach in hospital outpatient departments. Skin substitutes that are not licensed biologics now share one national rate of $127.14 per square centimeter, set after a November 2025 correction.

Alloskin is a human tissue allograft, not a product licensed under a Biologics License Application (BLA), so it falls under that flat rate. Consequently, product-specific average sales price (ASP) pricing and quarterly ASP updates no longer set its payment in the office or the hospital outpatient setting. Claims with dates of service through December 31, 2025 still follow the old ASP-based rules.

Good revenue cycle management for skin substitute codes now means checking each remittance against the flat rate multiplied by the billed units. Every product pays the same rate, so the unit count, and the graft measurement behind it, decides the payment. Practices that do not reconcile at the code level often find underpayments months later.

Local coverage determinations (LCDs) governing Q4115

Medicare coverage for Q4115 is governed by the Local Coverage Determination (LCD) of the MAC with jurisdiction over the provider’s service area. Meanwhile, LCD numbers, criteria and effective dates vary by MAC. New multi-MAC LCDs for skin substitutes on diabetic foot and venous leg ulcers were due on January 1, 2026. However, CMS withdrew them on December 24, 2025.

The CY 2026 reclassification of skin substitutes as incident-to supplies went ahead anyway, so payment and coverage now follow separate rules. Therefore, verify the active LCD in the CMS Medicare Coverage Database or on your MAC’s website.

The core coverage criteria shared across most MACs include:

• Wound chronicity – wound present for at least 30 days prior to the first skin substitute application (verify exact threshold with your MAC’s active LCD)
• Standard care failure – documented failure of conservative treatment including debridement, appropriate dressings, offloading or compression as indicated by wound type
• Wound measurement – wound size in sq cm documented at each visit, used to calculate billing units
• Physician attestation – ordering provider must confirm the wound meets LCD criteria in the clinical note
• Frequency limits – LCDs typically cap the number of skin substitute applications per wound episode; exceeding limits triggers automatic denial

Sound medical billing compliance for wound care codes means auditing every Q4115 claim against the LCD criteria. Run that audit before submission, instead of only at the point of service. Building the criteria into the clinical documentation template keeps that coverage support consistent from visit to visit.

Prior authorization and payer requirements for Q4115

Commercial payers usually require prior authorization (PA) for Q4115 before the first application. Traditional Medicare has no national PA requirement for skin substitutes, but a 2026 pilot adds one in four states.

Under the CMS WISeR model, which began on January 1, 2026, skin substitutes need PA or pre-payment review in four states. Specifically, those states are New Jersey, Ohio, Oklahoma and Texas. Arizona and Washington are also in the model, but CMS removed skin substitutes there because no skin substitute LCD applies. Check your MAC’s current WISeR guidance before the first application.

For commercial payers, PA is typically required before the first application. The documentation package submitted with a PA request should include:

• Wound photograph with measurement scale, dated within 30 days of the PA request
• Wound measurement in sq cm for each documented visit
• Treatment history showing standard care attempts and outcomes (minimum 30 days or per payer policy)
• Diagnosis codes with full specificity (laterality, depth, underlying condition)
• Physician clinical note confirming the wound meets the payer’s LCD or coverage policy criteria
• Product information for Q4115 (Alloskin and the graft size planned for use)

Unfortunately, incomplete PA packages are a common cause of delayed approvals on skin substitute claims. A clean claim for Q4115 starts with a complete PA package, assembled before the graft is applied.

How to document Q4115 for a clean claim

Clean claims for Q4115 depend on three documentation pillars: wound measurement accuracy, product traceability, and chronicity evidence. Missing any one of them generates either a payer edit or an auditor flag.

Two measurements drive a Q4115 claim. First, the wound’s surface area, read with its site, decides the CPT application code. Second, the size of the graft applied decides the Q4115 units. Both must be recorded in the clinical note for the same date of service. Therefore, you cannot estimate them or carry them forward from a prior visit.

1. Measure the wound at the visit – document length x width in centimeters; calculate sq cm (length x width = approximate area). Then record it in the clinical note with the date.
2. Record the graft identifiers and size – document the Alloskin lot or tissue identification number, the expiration date, and the size of the graft applied. Importantly, the billed sq cm must not exceed the graft size used.
3. Calculate billing units correctly – bill one unit of Q4115 per sq cm of Alloskin applied, following your MAC’s instructions on rounding.
4. Pair with the correct CPT code – confirm the wound site and total area. Select 15271 or 15275 by site for the first 25 sq cm, or 15273 or 15277 for the first 100 sq cm. Add-ons are 15272/15276 per 25 sq cm and 15274/15278 per 100 sq cm.
5. Document chronicity evidence – include the date the wound first appeared and a summary of all prior treatments. Confirm that at least 30 days of standard care preceded the first application.
6. Attach wound photographs – most payers expect dated photographs at baseline and at application visits; keep these in the medical record and produce them on request.

For this reason, a standard wound care visit template helps practices follow these steps the same way every time. Each visit then closes with the full evidence set attached to the encounter.

Common Q4115 denial reasons and how to fix them

Q4115 denial reasons follow predictable patterns. The table below maps the most frequent denial causes to their root problems and corrective actions. Overall, it draws on the LCD and CMS billing instructions for skin substitute codes.

Effective denial management strategies for Q4115 require tracking denial reason codes at the individual claim level, not just as aggregate rejection rates. Also watch for CO-50, CO-97, N130 and similar remittance advice remark codes. In fact, patterns in denial reason codes reveal whether the root problem is documentation, coding, or payer policy.

Q4115 vs related skin substitute codes: key differences

The Q4100 series contains dozens of individual skin substitute product codes. Selecting the wrong one when multiple products are stocked is an easy error that generates a product-code mismatch denial. The table below compares Q4115 with the codes it is most often confused with, including the two other AlloSource grafts.

Practices that also stock Flowerderm need a separate code for it. That human skin allograft bills under Q4179, again per square centimeter, so the two cannot be billed interchangeably.

The fastest way to confirm correct code assignment is to cross-reference the product label’s HCPCS code against the current CMS HCPCS alpha-numeric file. According to AAPC’s HCPCS code lookup, product-to-code assignments can be searched by product name to verify before billing. Run the same check when a new product joins your formulary mid-year.

How Pabau supports Q4115 documentation and claims

Many wound care practices bill Q4115 from two records that never meet. The wound measurement and graft size sit in the clinical note, while the units sit in a separate billing system. Consequently, each retype between them is a chance to bill units the chart cannot support.

Instead, Pabau keeps the clinical side in one patient record. Its customizable medical forms capture wound length, width, area, graft size and lot number at the visit, next to dated wound photos.

Pabau’s claims management then submits the claim through Claim.MD and tracks its status. As a result, your team sees each rejection or denial and works it from one place. When a MAC requests records, the measurement, graft details and photos are already on the encounter.

Keep Q4115 claims tied to the clinical record

Pabau keeps wound measurements and graft details in the patient record, then submits your Q4115 claims and tracks each denial until it is resolved.

Book a demo

Conclusion

Q4115 pays on two numbers the chart has to prove. One is the graft size behind the units, and the other is the wound area behind the CPT code. Under the 2026 flat rate, every non-BLA product pays the same per square centimeter, so those numbers now decide the payment.

Record both at the application visit, with the lot number and dated photos, and code the site before choosing between 15271 and 15275. Then confirm your MAC’s active LCD, and any WISeR review in your state, before the first graft goes on. Book a demo to see how Pabau keeps Q4115 documentation and claim tracking in one patient record.

Continue your research

Need to understand denial patterns across your wound care claims? Denial management in healthcare covers the systematic approach to identifying, appealing, and preventing recurring claim rejections.

Want a reference for how the HCPCS system is structured? What is medical billing explains the coding systems, payer types, and claim lifecycle that underpin Q4115 billing.

Want fewer Q4115 claims sent back? What is a clean claim explains what a payer needs to see to process a claim on the first pass.

Frequently asked questions